Perifosine – a new option in treatment of acute myeloid leukemia?

Author： Krawczyk Janusz   Keane Niamh   Swords Ronan   O'Dwyer Michael   Freeman Ciara L   Giles Francis J  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.10, 2013-10, pp. : 1315-1327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Raf Kinase in the Treatment of Acute Myeloid Leukemia

By  

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2243-2248

Bentham Science Publishers

Access to resources Recommend Favorite

The role of quizartinib in the treatment of acute myeloid leukemia

By Ostronoff Fabiana   Estey Elihu  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. : 1659-1669

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibodies for the Treatment of Acute Myeloid Leukemia

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 5, 2006-10 ,pp. : 343-369

Bentham Science Publishers

Access to resources Recommend Favorite

Lenalidomide as a novel treatment of acute myeloid leukemia

By Chen Yiming   Borthakur Gautam  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 389-397

Informa Healthcare

Access to resources Recommend Favorite

New therapeutic approaches to acute myeloid leukemia

By Uchida Hideo   Inokuchi Koiti   Watanabe Reiko   Tokuhira Michihide   Kizaki Masahiro  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 6, 2008-06 ,pp. : 689-706

Informa Healthcare

Access to resources Recommend Favorite